Article info

Download PDFPDF
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

Authors

  1. Correspondence to Eileen W Stalman, Department of Neurology and Neurophysiology, Amsterdam UMC Locatie AMC, Amsterdam, North Holland, Netherlands; e.w.stalman{at}amsterdamumc.nl
View Full Text

Citation

Wieske L, Stalman EW, van Dam PJK On behalf of the T2B! immunity against SARS-CoV-2 study group, et al
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

Publication history

  • Received October 12, 2022
  • Accepted January 16, 2023
  • First published January 31, 2023.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.